Literature DB >> 33882765

How treatable is narcolepsy with current pharmacotherapy and what does the future hold?

Gaia Pellitteri1,2, Stefano de Biase3, Mariarosaria Valente1,2, Gian Luigi Gigli1,2.   

Abstract

Entities:  

Year:  2021        PMID： 33882765     DOI： 10.1080/14656566.2021.1915987

Source DB:  PubMed          Journal:  Expert Opin Pharmacother        ISSN： 1465-6566            Impact factor:   3.889


× No keyword cloud information.
  2 in total

1.  Clinical Impact of Pitolisant on Excessive Daytime Sleepiness and Cataplexy in Adults With Narcolepsy: An Analysis of Randomized Placebo-Controlled Trials.

Authors:  Gerard J Meskill; Craig W Davis; Donna Zarycranski; Markiyan Doliba; Jean-Charles Schwartz; Jeffrey M Dayno
Journal:  CNS Drugs       Date:  2021-12-21       Impact factor: 5.749

2.  Examining the impact of excessive daytime sleepiness on utility scores in patients with obstructive sleep apnoea and/or narcolepsy in five European countries.

Authors:  M Janelle Cambron-Mellott; Sam Mettam; Vicky W Li; John C Rowland; JeanPierre Coaquira Castro
Journal:  BMC Neurol       Date:  2022-08-25       Impact factor: 2.903
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.